Form 4: Amphenol Executive Sells $14.4M in Stock

Amphenol's Sr. VP, Secretary & GenCounsel, Lance E. D'Amico, exercised stock options and sold 130,000 shares of Class A Common Stock for approximately $14.4 million.

Summary

• Lance E. D'Amico, Amphenol's Sr. VP, Secretary & GenCounsel, executed pre-planned stock option exercises and sales on August 18, 2025.
• He directly exercised options for 100,000 Class A Common Stock shares at an exercise price of $22.5525 per share and subsequently sold these shares at a weighted average price of $110.6003 per share.
• An additional 30,000 Class A Common Stock shares were acquired through option exercise at $22.3725 per share by the Lance E. D'Amico 2024 Irrevocable Trust and then sold at a weighted average price of $110.8083 per share.
• The total estimated proceeds from these sales amount to approximately $14,384,279.
• Following these transactions, D'Amico directly holds 76,400 shares and indirectly holds 76,400 shares through the 2024 Irrevocable Trust, and 25,000 shares through the 2025 GRAT #1.
• All reported transactions were executed pursuant to a Rule 10b5-1(c) plan.

Sentiment

Score: 6

Explanation: The sentiment is neutral to slightly positive. While insider selling can sometimes be viewed negatively, the fact that it's an exercise of options and a sale under a 10b5-1 plan makes it a routine liquidity event rather than a signal of negative sentiment about the company's future. It reflects the executive realizing value from long-term compensation.

Positives

• The transactions were executed under a Rule 10b5-1(c) plan, indicating pre-scheduled sales rather than a reaction to new, non-public information, which can reduce negative market perception.
• The significant profit realized from the option exercises and sales demonstrates the long-term value creation for executives through equity compensation.

Negatives

• Insider selling, even if pre-planned, can sometimes be perceived negatively by the market as it reduces the insider's direct equity stake, though this is mitigated by the 10b5-1 plan.

Future Outlook

NA

Industry Context

NA

Related Party Transactions

• The sale of 30,000 shares was conducted indirectly through the Lance E. D'Amico 2024 Irrevocable Trust, which is a related party.
• Lance E. D'Amico also holds 25,000 shares indirectly through the Lance E. D'Amico 2025 GRAT #1, another related party.

Stakeholder Impact

• Shareholders: The sale of shares by a senior executive could be perceived as a slight reduction in insider alignment, though this is mitigated by the 10b5-1 plan. The total number of shares sold (130,000) is a very small fraction of Amphenol's total outstanding shares, so the direct market impact is likely minimal.
• Employees: No direct impact on employees is indicated.
• Customers/Suppliers/Creditors: No direct impact on these stakeholders is indicated.

Key Dates

Recommendation

The filing is a routine Form 4 detailing an executive's exercise of stock options and subsequent sale of shares under a pre-arranged 10b5-1 plan. This type of transaction is common for executives seeking to diversify their personal holdings or manage liquidity and does not typically signal a change in the company's fundamental outlook or performance. Therefore, it provides no new information that would warrant a change in investment recommendation based solely on this filing.

Keywords

Amphenol, APH, Insider Trading, Form 4, Stock Option Exercise, Executive Compensation, Stock Sale, D'Amico Lance E, 10b5-1 Plan